Bibliography
- ULLRICH A, SCHLESSINGER J: Signal transduction by receptors with tyrosine kinase activity. Cell (1990) 61:203–209.
- LIA X, PAWSON T: Biochemistry of the Src protein tyrosine kinase: regulation by S112 and S113 domains. Recent Prog. Horm. Res. (1994) 49:149–160.
- LEVITZKI A, GAZIT A: Tyrosine kinase inhibition: an approach to drug development. Science (1995) 267:1782–1788.
- GOLDEN A, BRUGGE JS: The sir oncogene. In: The Onco-gene Handbook. Reddy EP, Skalka AM, Curran T (Eds.), Elsevier (1988):149–173.
- LEVITSKI A: Src as a target for anticancer drugs. Anti Cancer Drug Des. (1996) 11:175–182.
- TANIGUCHI T: Cytokine signalling through nonrecep-tor protein tyrosine kinases. Science 268:251–255.
- SORIANO P, MONTGOMERY C et al.: Targeted disruption of the c-src protoponcogene leads to osteopetrosis in mice. Cell (1991) 64:693–702.
- BOYCE BF et al.: Requirement of pp60' expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. (1992) 90:1622–1627.
- FARLEY K, METT H, McGLYNN E et al.: Development of solid-phase enzyme-linked immunosorbent assays for the determination of epidermal growth factor receptor and pp60c-sit tyrosine protein kinase activity. Analy. Biochem. (1992) 203:151–157.